The World's most accurate pet cancer test?

THE PROBLEM

Identifying developing cancer in pets that are unable to communicate their discomfort or illness

ALERTIX'S SOLUTION

A simple blood sample is all it takes to measure an important biomarker for cell growth using a unique immunochemical method.

ADVANTAGES

Unlike other tests, Alertix’s method also detects solid tumors.
Based on one blood sample – affordable, simple and painless!

RESULT

Early detection is crucial. Alertix’ assay can give animal owners better decision support, and a chance to earlier treatment

Alertix Canine - for Dogs

Assay for early detection, monitoring and screening of tumor diseases in dogs. The assay is available to veterinary clinics and laboratories in Sweden and Scandinavia, and soon in the US.

Alertix Feline - for Cats

Assay for early detection, monitoring and screening of tumor diseases in cats.

 
The assay is under development.

Alertix Equine - for Horses

Assay for early detection, monitoring and screening of tumor diseases in horses.


The assay is under development.

About cancer in companion animals

Did you know that our companion animals are afflicted by cancer as often as humans? Dogs and cats share not only our living environment but also our lifestyle. Because of this they are exposed to the same risk factors for cancer.

Veterinary care is getting better and better at treating cancer in companion animals. But the crucial factor of success is that the disease is detected in time. And that treatments are monitored.

Subscribe to our newsletter

Stay up-to-date on canine cancer and how you can protect your dog. Sign up for our newsletter today!

Our Latest News

Unique assay for cancer diseases in dogs, cats and horses

Alertix Veterinary Diagnostics AB was founded in 2017. Our goal is to develop discoveries from Swedish veterinary medical biotech research. In particular concerning a new, powerful method for measuring the presence of the enzyme thymidine kinase 1 (TK1) in serum of animals important in veterinary medicine.

TK1 is a biomarker for tumor growth and cell turnover. The substance has been detected in serum of patients even before they show clinical symptoms. This means that the assay can be a valuable tool for early diagnosis of cancer diseases.